Plasma exosomal CD48 protein as a candidate diagnostic biomarker for hepatocellular carcinoma
Background and purpose: Approximately 60% of patients with hepatocellular carcinoma (HCC) are diagnosed at an advanced stage, therefore cannot receive timely and effective treatment. At present, the sensitivity of serum biomarkers commonly used in the diagnosis of HCC is low. In this paper, through...
Збережено в:
| Автор: | |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Editorial Office of China Oncology
2022-11-01
|
| Серія: | Zhongguo aizheng zazhi |
| Предмети: | |
| Онлайн доступ: | http://www.china-oncology.com/fileup/1007-3639/PDF/1670982853142-1120678565.pdf |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|